Takeda Pharmaceutical (TAK) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Takeda Pharmaceutical (TAK) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -75.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.69% |
| Mar 31, 2026 | 12.75% |
| Dec 31, 2025 | 83.30% |
| Sep 30, 2025 | 11.50% |
| Jun 30, 2025 | 14.06% |
| Mar 31, 2025 | -55.25% |
| Dec 31, 2024 | 37.46% |
| Sep 30, 2024 | 0.52% |
| Jun 30, 2024 | 7.29% |
| Mar 31, 2024 | -102.01% |
| Dec 31, 2023 | 7.62% |
| Sep 30, 2023 | -45.45% |
| Jun 30, 2023 | 7.46% |
| Mar 31, 2023 | -69.72% |
| Sep 30, 2022 | -17.37% |
| Jun 30, 2022 | -40.40% |
| Mar 31, 2022 | 813.97% |
| Dec 31, 2021 | 20.95% |
| Sep 30, 2021 | 99.99% |
| Jun 30, 2021 | 19.41% |